Louis Bock - Profile and Investment Details

Investor Profile

Louis Bock is a Venture Capital, Private Equity Firm, Investor based in Austin, Texas, United States with a diverse investment portfolio that includes companies such as HNI Healthcare, Ketra, diaDexus, Healthcare Highways, Nirogy Therapeutics, New Century Hospice, Claret Medical, Iterion Therapeutics, Seattle Genetics, Zeno Corporation, Zogenix, Terapio, RiseHealth, Rex Bionics, CardioKinetixRenascent Medical, Lumos Pharma, Explorys, Protein Discovery, Guided Interventions, Farapulse, LumaTherm, Geneos Therapeutics, TVA Medical, kēlaHealth, Spinal Restoration, DyaMX, BioStable, Cryosa, Lyric Pharmaceuticals, BAROnova, Orexigen Therapeutics, Skysong Innovations (SI), Horizon Pharma plc, PowerVision, Millipede, Heat Biologics, Molecular Templates, Mirna Therapeutics, AbVitro, Remedy, Gilead Sciences, Libra Therapeutics, EndoStim, Glyscend, New Century Hospice, Inc., Laguna Pharmaceuticals, . Over time, Louis Bock has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Louis Bock is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Telecommunications, Hospitals, Data Science, Healthcare Delivery, Wellness, Women Founded, Enterprise Software, Outpatient Care, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Information Services, Information Technology (IT), Venture Fundraising, Technology, Finance, Software, Biotechnology, Medical Devices, Hispanic / Latinx Founded, Productivity Software, Landscaping, Clinical Trials, Disruptive technology, Natural Language Processing, Consumer Software, Health Diagnostics, Medical, Big Data, Information Technology, B2B, Therapeutics, Health Tech, Media and Entertainment, Machine Learning, Cosmetic Surgery, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Louis Bock, as their portfolio suggests a familiarity and interest in this area.

Understanding Louis Bock’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.